Neurocrine Biosciences (NBIX) Inventory Average (2017 - 2026)
Neurocrine Biosciences (NBIX) posted quarterly Inventory Average of $84.4 million for Q2 2026, up 45.43% year-over-year from $58.0 million in Q2 2025, and up 26.37% on a QoQ basis from $66.8 million in Q1 2026.
Neurocrine Biosciences (NBIX) Inventory Average (2017 - 2026) Analysis & Trends
Neurocrine Biosciences has reported Inventory Average for 10 years, with the latest figure at $84.4 million in Q2 2026.
- Inventory Average for Q2 2026 came in at $84.4 million, up 45.43% year-over-year; the trailing twelve-month figure through Jun 2026 was $84.4 million (up 45.43% YoY), and the FY2025 annual result was $63.2 million, up 32.08% from the prior year.
- Inventory Average rose to $84.4 million in Q2 2026, from $66.8 million in the prior quarter.
- Over five years, Inventory Average peaked at $84.4 million in Q2 2026 and troughed at $29.2 million in Q2 2022.
- A 5-year average of $46.2 million and a median of $38.8 million in 2024 frame the typical range for Inventory Average.
- The widest annual swing landed in 2023, when Inventory Average retreated 8.75%; it then surged 54.3% in 2025.
- A 5-year view of Inventory Average shows it stood at $36.0 million in 2022, then retreated by 6.93% to $33.6 million in 2023, then jumped by 53.8% to $51.6 million in 2024, then soared by 34.01% to $69.1 million in 2025, then gained by 21.98% to $84.4 million in 2026.
- Per Business Quant data, the three most recent Inventory Average figures were $84.4 million in Q2 2026, $66.8 million in Q1 2026, and $69.1 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | 1.41 Bn |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | 3.20 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 2.56 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 8.99 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 186.05 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 84.35 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 1.74 Bn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | 824.00 Mn |
| 10 | Alkermes | 8.20 Bn | 7.54 Bn | 397.90 Mn | 317.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 84.35 Mn |
| Mar 31, 2026 | 66.75 Mn |
| Dec 31, 2025 | 69.15 Mn |
| Sep 30, 2025 | 63.10 Mn |
| Jun 30, 2025 | 58.00 Mn |
| Mar 31, 2025 | 58.25 Mn |
| Dec 31, 2024 | 51.60 Mn |
| Sep 30, 2024 | 44.15 Mn |
| Jun 30, 2024 | 39.85 Mn |
| Mar 31, 2024 | 37.75 Mn |
| Dec 31, 2023 | 33.55 Mn |
| Sep 30, 2023 | 30.25 Mn |
| Jun 30, 2023 | 32.55 Mn |
| Mar 31, 2023 | 34.25 Mn |
| Dec 31, 2022 | 36.05 Mn |
| Sep 30, 2022 | 33.15 Mn |
| Jun 30, 2022 | 29.15 Mn |
| Mar 31, 2022 | 29.75 Mn |
| Dec 31, 2021 | 28.00 Mn |
| Sep 30, 2021 | 26.90 Mn |